Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Muto

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
Elife|July 28, 2016
Tissue damage drives co-localization of NF-κB, Smad3, and Nrf2 to direct Rev-erb sensitive wound repair in mouse macrophagesDawn Z Eichenfield, Ty Dale Troutman, Verena M Link, et al.
Scientific Reports|January 11, 2025
Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapyShigeo Ohba, Takao Teranishi, Kazuyasu Matsumura, et al.
Journal of Neurosurgery|August 30, 2024
Long-term survivors in 976 supratentorial glioblastoma, IDH-wildtype patientsOumaima Aboubakr, Alessandro Moiraghi, Angela Elia, et al.
Journal of Neuro-Oncology|October 16, 2025
High-grade glioma, IDH- and H3-wildtype in young adults: a rare condition with a distinct epigenetic landscapeAlexandre Roux, Arnault Tauziede-Espariat, Giorgia Antonia Simboli, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
Elife|July 28, 2016
Tissue damage drives co-localization of NF-κB, Smad3, and Nrf2 to direct Rev-erb sensitive wound repair in mouse macrophagesDawn Z Eichenfield, Ty Dale Troutman, Verena M Link, et al.
Scientific Reports|January 11, 2025
Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapyShigeo Ohba, Takao Teranishi, Kazuyasu Matsumura, et al.
Journal of Neurosurgery|August 30, 2024
Long-term survivors in 976 supratentorial glioblastoma, IDH-wildtype patientsOumaima Aboubakr, Alessandro Moiraghi, Angela Elia, et al.
Journal of Neuro-Oncology|October 16, 2025
High-grade glioma, IDH- and H3-wildtype in young adults: a rare condition with a distinct epigenetic landscapeAlexandre Roux, Arnault Tauziede-Espariat, Giorgia Antonia Simboli, et al.
Pageof 17